Scientific Workshop on Understanding and Overcoming Tumor-intrinsic Resistance to CAR-T Therapies for Lymphoid Malignancies
Program: Scientific Workshops
Session: Examining the Malignant Genome in CAR-T Patients
Program: Scientific Workshops
Session: Examining the Malignant Genome in CAR-T Patients
Friday, December 6, 2024, 3:42 PM-4:18 PM
Disclosures: Schatz: Affimed NV: Consultancy; WCG: Consultancy; Acrotech Biopharma Inc.: Membership on an entity's Board of Directors or advisory committees.
See more of: Examining the Malignant Genome in CAR-T Patients
See more of: Scientific Workshop on Understanding and Overcoming Tumor-intrinsic Resistance to CAR-T Therapies for Lymphoid Malignancies
See more of: Scientific Workshops
See more of: Scientific Workshop on Understanding and Overcoming Tumor-intrinsic Resistance to CAR-T Therapies for Lymphoid Malignancies
See more of: Scientific Workshops
Previous Presentation
|
Next Presentation >>